Geyser Brands recently received a processing license and implemented manufacturing at a licensed production (LP) facility The company developed NanoFusion, an advanced nanotechnology drug-delivery system GYSR recently acquired Solace Management Group Inc. Now that cannabis is losing its illegitimacy, derivatives of the plant are permeating consumer markets at a rapidly growing pace, thanks to companies … Continue reading “Geyser Brands Inc. (TSX.V: GYSR) Delivers Established Cannabis Labels to Consumer Health Care Markets”
Global science-led, consumer, health-care company Geyser Brands (TSX.V: GYSR) is continuing to achieve its strategic goals. An article discussing the company reads, “Financial statements for the three months ended June 30, 2019, show Geyser Brands reporting revenues of $79,434, representing an 81% gross profit margin. . . . ‘We have begun to operationalize our manufacturing … Continue reading “CannabisNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Achieves 81% Gross Profit Margin in Q1 2019”
Geyser Brands (TSX.V: GYSR) recently reported notable financial results for the eight months ended March 31, 2019 (http://cnw.fm/4Wa6M). An article discussing the company reads, “‘We are pleased with our progress in the first eight months since completing the RTO. Our subsidiary, 0957203 B.C. Ltd. dba Apothecary Botanicals, through its strong management, has been successful in bringing … Continue reading “CannabisNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Demonstrates Growth with Encouraging Financial Results”
Geyser Brands’ first revenues of $79,434, generated during Q1 2019, represent a gross profit margin of 81 percent The company is nearing final TSX Venture Exchange conditional approval of its transaction to acquire Solace Management Group Inc. Geyser Brands subsidiary Apothecary Botanicals has received a standard processing license from Health Canada, which will allow the … Continue reading “Geyser Brands Inc. (TSX.V: GYSR) Generates First Revenues, Anticipates Receipt of Additional Health Canada Licenses”
Geyser Brands (TSX.V: GYSR) this morning released its first quarter financial statements for the three months ended June 30, 2019. According to the update, the company generated its first revenues of $79,434 during the quarter and reported $64,690 in gross profit, representing an 81 percent gross profit margin. In addition, Geyser Brands announced that, in … Continue reading “CannabisNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Releases Q1 Financial Results, Provides Solace Acquisition Update”
Geyser Brands (TSX.V: GYSR) this morning announced its post-RTO audited financial statements (“Annual Financial Statement”) for the 8-months ended March 31, 2019, as well as accompanying management discussion and analysis. According to the update, the Annual Financial Statement represents Geyser’s transitional fiscal year following its RTO and change in the fiscal year end, which is … Continue reading “CannabisNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Releases Post-RTO Financial Results for the 8-months ended March 31, 2019”
Geyser Brands (TSX.V: GYSR) announced key appointments to its leadership team recently, including the addition of Dr. Bin Huang to the company’s board of directors (http://cnw.fm/c6cFk). An article discussing the company reads, “Joining the board of directors is Dr. Bin Huang, a seasoned, life-sciences executive with experience in strategy and new business development, financing and … Continue reading “CannabisNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Appoints Seasoned Life Sciences Executive to Board of Directors”
Geyser Brands’ (TSX.V: GYSR) wholly owned subsidiary, Apothecary Botanicals, recently achieved a major milestone when it received its standard processing license, enabling Geyser to advance its brands (http://cnw.fm/8FyOi). An article discussing the company reads, “The new license allows Geyser to begin work to extend its cannabidiol products to the regulated Canadian consumer medical market as the … Continue reading “CannabisNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Subsidiary Secures Coveted Standard Processing License”
Seasoned life sciences executive Dr. Bin Huang has been appointed to the Geyser board of directors Chartered Professional Account Gordon Clissold has been named chief executive officer Geyser Brands is entering into a definitive agreement for the acquisition of Solace Management Group, which will broaden the company’s range of CBD- and hemp-based products Geyser Brands … Continue reading “Geyser Brands Inc. (TSX.V: GYSR) Strengthens Leadership with Key Appointments”
Geyser Brands is a cannabis consumer wellness company dedicated to helping people look, feel and do their best The company announced June 18 that wholly owned subsidiary Apothecary Botanicals has been awarded a processing license, allowing GYSR to advance its brands Geyser’s LOI to acquire Solace Management Group is expected to give the company additional … Continue reading “Geyser Brands Inc. (TSX.V: GYSR) Reaches Milestone in CBD Wellness Market with Reception of Processing License”
